Mucociliary Clearance Techniques for Acute Bronchiolitis

To assess the efficacy of mucociliary clearance techniques in non-hospitalised infants with a first episode of mild to moderate acute bronchiolitis.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Acute Bronchiolitis Due to Respiratory Syncytial Virus Bronchiolitis Acute Bronchiolitis Acute Viral

Age range

28 day–12 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Medical diagnosis of first episode of acute Bronchiolitis.
Acute Bronchiolitis with mild (ESBA score = 1-4) or moderate (ESBA score =5-9) severity according to the ESBA.
Informed consent signed by parents or legal guardians.

Exclusion criteria

Infants previously diagnosed with chronic respiratory disease.
Previous episodes of wheezing.
Presence of any type of contraindication to receive Respiratory Physiotherapy treatment.

Treatment and study plan

Respiratory Physiotherapy

Procedure

Mucociliary clearance techniques (prolonged slow expiration and provoked cough), bronchodilator when prescribed and nebulisation with 3% hypertonic saline.

Primary outcomes

ESBA

Time frame: 1 session (45 minutes)

The variables collected using the ESBA scale were: wheezing, crackles, inspiratory effort, Inspiratory/Expiratory ratio, respiratory rate and heart rate.

Study contacts

Contact information is provided by the study sponsor or research team.

Raquel Leirós-Rodríguez, PhD.

CONTACT

[email protected]

+34 987 44 20 00

Sponsors and collaborators

Lead sponsor

Universidad de León

Other

Registry information

Official study title

Efficacy of Mucociliary Clearance Techniques in Non-hospitalised Infants with Acute Bronchiolitis

Acronym: CLEARBRONCH

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Nov 14, 2024
Registry last updated: Nov 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting